Tina M. Kaufman, PhD, PA-C; Sergio Fazio, MD, PhD; Michael D. Shapiro, DO
Grant Support: Dr. Shapiro is supported by grant K12 HD043488 from the National Institutes of Health.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3009.
Corresponding Author: Michael D. Shapiro, DO, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239; e-mail, email@example.com.
Current Author Addresses: Drs. Kaufman, Fazio, and Shapiro: Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239.
Author Contributions: Conception and design: T.M. Kaufman, S. Fazio, M.D. Shapiro.
Analysis and interpretation of the data: T.M. Kaufman.
Drafting of the article: T.M. Kaufman, S. Fazio.
Critical revision of the article for important intellectual content: T.M. Kaufman, S. Fazio, M.D. Shapiro.
Final approval of the article: S. Fazio, M.D. Shapiro.
Collection and assembly of data: T.M. Kaufman.
Kaufman TM, Fazio S, Shapiro MD. Brief Commentary: Marijuana and Cardiovascular Disease—What Should We Tell Patients?. Ann Intern Med. 2019;170:119–120. [Epub ahead of print 8 January 2019]. doi: https://doi.org/10.7326/M18-3009
Download citation file:
Published: Ann Intern Med. 2019;170(2):119-120.
Published at www.annals.org on 8 January 2019
Cardiology, Tobacco, Alcohol, and Other Substance Abuse.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use